Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism

Toxicology and Applied Pharmacology

Volumn 146, Issue 1, 1997, Pages 116-126

  Obourn, John D ^a   Frame, Steven R ^a   Chiu, Taisan ^a   Solomon, Travis E ^b   Cook, Jon C ^a  

^a DUPONT COMPANY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 8947; CHOLECYSTOKININ; DEVAZEPIDE; HERBICIDE; SULFONYLUREA DERIVATIVE; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPERTROPHY; MALE; NONHUMAN; ORGAN WEIGHT; PANCREAS ISLET CELL HYPERPLASIA; RAT;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030930251     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8231     Document Type: Article

References (41)

1. Andren-Sandberg A. A., Dawiskiba S., Ihse I. Studies of the effect of cerulein administration on experimental pancreatic carcinogenesis. Scand. J. Gastroenterol. 19:1984;122-128.
2. Becker R. R. Inhibition of spontaneous hepatogenesis in C3H/HeN mice by Edipro A, an isolated soy protein. Carcinogenesis. 2:1981;1213-1214.
3. Booth A. N., Robbins D. J., Ribelin W. E., DeEds F. Effects of raw soybean meal and amino acids on pancreatic hypertrophy in rats. Proc. Soc. Exp. Biol. Med. 104:1960;681-683.
4. Cotran R. S., Kumar V., Robbins S. L. The pancreas. Pathologic Basis of Disease. 1989;W. B. Saunders, Philadelphia. p. 981-1010.
5. Ge Y. C., Morgan R. G. H. The effect of trypsin inhibitor on the pancreas and small intestine of mice. Br. J. Nutr. 70:1993;333-345.
6. Goke B., Fenchel K., Knobloch S., Arnold R. R., Adler G. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Pancreas. 3:1988;576-579.
7. Herrington M. K., Permert J., Kazadoff K. R., Zucker K. A., Bilchik A. J., Pour P. M., Adrian T. E. Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. Cancer Lett. 82:1994;7-16.
8. Howatson A. G., Carter D. C. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model. Br. J. Cancer. 51:1985;107-114.
9. Innis R. B., Snyder S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. 77:1980;6239-6243.
10. Iwai K., Fushiki T., Fukuoka S.-I. Pancreatic enzyme secretion mediated by novel peptide: Monitor peptide hypothesis. Pancreas. 3:1988;720-728.
11. Johnson F. E., LaRegina M. C., Martin S. A., Bashiti H. M. Cholecystokinin inhibits pancreatic and hepatic carcinogenesis. Cancer Detect. Prev. 6:1983;389-402.
12. Johnson L. R. Effects of gastrointestinal hormones on pancreatic growth. Cancer. 47:1981;1640-1645.
13. Johnson L. R. Cholecystokinin. Physiology of the Gastrointestinal Tract. 1987;Raven Press, New York. p. 195-205.
14. Liener I. E. Trypsin inhibitors: Concern for human nutrition or not? J. Nutr. 116:1986;920-923.
15. Longnecker D. Early morphologic markers of carcinogenicity in rat pancreas. Milman H., Sell S. Application of Biological Markers to Carcinogen Testing. 1983;43-60 Plenum Press, New York.
16. Longnecker D. Interface between adaptive and neoplastic growth in the pancreas. Gut. 28:1987;253-258.
17. Longnecker D. S., Sumi C. Effects of sex steroid hormones on pancreatic cancer in the rat. Intl. J. Pancreatol. 7:1990;159-165.
18. Loser C., Folsch U. R., Mustroph D., Cantor P., Wunderlich U., Creutzfeldt W. Pancreatic polyamine concentrations and cholecystokinin plasma levels in rats after feeding raw or heat-inactivated soybean flour. Pancreas. 3:1988;285-291.
19. Louie D. S., May D., Miller P., Owyang C. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am. J. Physiol. 13:1986;G252-G259.
20. Lutcke H., Scheele G. A., Kern H. F. Time course and cellular site of mitiotic activity in the exocrine pancreas of the rat during sustained hormone stimulation. Cell Tissue Res. 247:1987;385-391.
21. McGuinness E. E., Morgan R. G. H., Wormsley K. G. Fate of pancreatic nodules induced by raw soya flour in rats. Gut. 28:1987;207-212.
22. McGuinness E. E., Morgan R. G. H., Levison D. A., Frape D. L., Hopwood D., Wormsley K. G. The effects of long-term feeding of soya flour on the rat pancreas. Scand. J. Gastroenterol. 15:1980;497-502.
23. Meijers M., van Garderen-Hoetmer A., Lamers C. R. H. W., Rovati L. C., Jansen J. B. M. J., Woutersen R. A. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters. Carcinogenesis. 11:1990;2223-2226.
24. Messadi D. V., Billings P., Shklar G., Kennedy A. R. Inhibition of oral carcinogenesis by a protease inhibitor. J. Natl. Cancer Inst. 76:1986;447-452.
25. Messina M., Messina V. Increasing use of soyfoods and their potential role in cancer prevention. J. Am. Diet Assoc. 1991;836-840.
26. Miller R. W. Epidemiology. Kaplan H. S., Tsuchitani P. J. Cancer in China. 1978;39-57 Alan R. Liss, New York.
27. Miyasaka K., Nakamura R., Funakoshi A., Kitani K. Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats. Pancreas. 4:1989;139-144.
28. Oates P. S., Morgan R. G. H. Pancreatic growth and cell turnover in the rat fed raw soya flour. Am. J. Pathol. 108:1982;217-224.
29. Oates P. S., Morgan R. G., Light A. M. Cell death (apoptosis) during pancreatic involution after raw soya flour. Am. J. Physiol. 250:1986;G9-G14.
30. Petersen H., Solomon T. E., Grossman M. I. Effect of chronic pentagastrin, cholecystokinin and secretin on pancreas of rats. Am. J. Physiol. 234:1978;E283-E286.
31. Pour P. M., Lawson T., Helgeson S., Donnelly T., Stepan K. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model. Carcinogenesis. 9:1988;597-601.
32. Roebuck B. D., Kaplita P. V., Edwards B. R., Praissman M. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Cancer Res. 47:1987;1333-1338.
33. Solomon T. E. Regulation of pancreatic secretion. Clin. Gastroenterol. 13:1984;657-678.
34. Turkelson C. M., Dale W. E., Reidelberger R., Solomon T. E. Development of the cholecystokinin radioimmunoassay using synthetic CCK-10 as immunogen. Regul. Peptides. 15:1986;205-217.
35. Turkelson C. M., Solomon T. E. Molecular forms of cholecystokinin in the rat intestine. Am. J. Physiol. 259:1990;G364-G371.
36. Wank S. A. Cholecystokinin receptors. Am. J. Physiol. 269:1995;G628-646.
37. Wank S. A., Pisegna J. R., de Weerth A. Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann. N.Y. Acad. Sci. 713:1994;49-66.
38. Weed H. G., McGandy R. B., Kennedy A. R. Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor. Carcinogenesis. 6:1985;1239-1241.
39. Wennogle L., Steel D., Petrack B. Characterization of central CCK receptors using a radioiodinated octapeptide probe. Life Sci. 36:1985;1485-1492.
40. Williams J. A., Blevins G. T. Cholescystokinin and regulation of pancreatic acinar cell function. Phys. Rev. 73:1993;701-723.
41. Zucker K. A., Adrian T. E., Bilchik A. J., Modlin I. M. Effects of CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Am. J. Physiol. 257:1989;G511-G516.